Cite
HARVARD Citation
Anders, C. et al. (2022). Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer. Journal for immunotherapy of cancer. 10 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Anders, C. et al. (2022). Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer. Journal for immunotherapy of cancer. 10 (2), p. . [Online].